Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya

City of Hope brings evidence-based approaches to integrative oncology

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

Cancer Policy

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

COI statement prohibits “unseemly advocacy,” “undue influence” by industry rep on ODAC

Columbia settles with Trump, agreeing to a $200M fine, as Harvard fights on

NIH says it’s moving away from animal-based models

Clinical Roundup

Tagrisso + chemo improve OS in EGFR-mutated advanced lung cancer, phase III trial shows

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

Tumor-infiltrating clonal hematopoiesis findings validated by AI analysis

Van Andel scientists develop improved single-cell DNA methylation technique

Researchers develop nicotinamide N-methyl transferase inhibitor to block ovarian cancer tumor growth

Study reveals immune-based therapy that may be effective in hard-to-treat lung cancers

In The Clinic

First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI

An overlooked immune cell population may offer new direction for cell and gene therapy

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Latest Issue

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Sep 2025

Oct 2025

Conversations with The Cancer Letter

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Contributors

Jeff Sorenson

Robert Peter Gale, MD, PhD, DSc (hon), FACP, FRCP, FRCPI(hon), FRSM

Charles Brenner, PhD

George J. Weiner, MD

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya

City of Hope brings evidence-based approaches to integrative oncology

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

COI statement prohibits “unseemly advocacy,” “undue influence” by industry rep on ODAC

Columbia settles with Trump, agreeing to a $200M fine, as Harvard fights on

NIH says it’s moving away from animal-based models

Tagrisso + chemo improve OS in EGFR-mutated advanced lung cancer, phase III trial shows

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

Tumor-infiltrating clonal hematopoiesis findings validated by AI analysis

Van Andel scientists develop improved single-cell DNA methylation technique

Researchers develop nicotinamide N-methyl transferase inhibitor to block ovarian cancer tumor growth

Study reveals immune-based therapy that may be effective in hard-to-treat lung cancers

First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI

An overlooked immune cell population may offer new direction for cell and gene therapy

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Jeff Sorenson

Robert Peter Gale, MD, PhD, DSc (hon), FACP, FRCP, FRCPI(hon), FRSM

Charles Brenner, PhD

George J. Weiner, MD

Never miss an issue!

Login

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

HHS seems poised to exert control over USPSTFRansohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Never miss an issue!

Login

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine